These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 27402017)
1. Allelic and Epitopic Characterization of Intra-Kidney Allograft Anti-HLA Antibodies at Allograft Nephrectomy. Milongo D; Kamar N; Del Bello A; Guilbeau-Frugier C; Sallusto F; Esposito L; Dörr G; Blancher A; Congy-Jolivet N Am J Transplant; 2017 Feb; 17(2):420-431. PubMed ID: 27402017 [TBL] [Abstract][Full Text] [Related]
2. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis. Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738 [TBL] [Abstract][Full Text] [Related]
3. Anti-human leukocyte antigen immunization after early allograft nephrectomy. Del Bello A; Congy N; Sallusto F; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Game X; Blancher A; Rostaing L; Kamar N Transplantation; 2012 May; 93(9):936-41. PubMed ID: 22361471 [TBL] [Abstract][Full Text] [Related]
4. Transcriptional Changes in Kidney Allografts with Histology of Antibody-Mediated Rejection without Anti-HLA Donor-Specific Antibodies. Callemeyn J; Lerut E; de Loor H; Arijs I; Thaunat O; Koenig A; Meas-Yedid V; Olivo-Marin JC; Halloran P; Chang J; Thorrez L; Kuypers D; Sprangers B; Van Lommel L; Schuit F; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M J Am Soc Nephrol; 2020 Sep; 31(9):2168-2183. PubMed ID: 32641395 [TBL] [Abstract][Full Text] [Related]
5. Eplet Mismatch Load and Senev A; Coemans M; Lerut E; Van Sandt V; Kerkhofs J; Daniëls L; Driessche MV; Compernolle V; Sprangers B; Van Loon E; Callemeyn J; Claas F; Tambur AR; Verbeke G; Kuypers D; Emonds MP; Naesens M J Am Soc Nephrol; 2020 Sep; 31(9):2193-2204. PubMed ID: 32764139 [TBL] [Abstract][Full Text] [Related]
6. A paired kidney analysis on the impact of pre-transplant anti-HLA antibodies on graft survival. Michielsen LA; Wisse BW; Kamburova EG; Verhaar MC; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JF; Hepkema BG; Lambeck AJ; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG; van Zuilen AD Nephrol Dial Transplant; 2019 Jun; 34(6):1056-1063. PubMed ID: 30365008 [TBL] [Abstract][Full Text] [Related]
7. Shared alloimmune responses against blood and transplant donors result in adverse clinical outcomes following blood transfusion post-renal transplantation. Hassan S; Regan F; Brown C; Harmer A; Anderson N; Beckwith H; Roufosse CA; Santos-Nunez E; Brookes P; Taube D; Willicombe M Am J Transplant; 2019 Jun; 19(6):1720-1729. PubMed ID: 30582278 [TBL] [Abstract][Full Text] [Related]
8. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation. Lachmann N; Niemann M; Reinke P; Budde K; Schmidt D; Halleck F; Pruß A; Schönemann C; Spierings E; Staeck O Am J Transplant; 2017 Dec; 17(12):3076-3086. PubMed ID: 28613392 [TBL] [Abstract][Full Text] [Related]
9. Donor-specific antibodies after ceasing immunosuppressive therapy, with or without an allograft nephrectomy. Del Bello A; Congy-Jolivet N; Sallusto F; Guilbeau-Frugier C; Cardeau-Desangles I; Fort M; Esposito L; Guitard J; Cointault O; Lavayssière L; Nogier MB; Blancher A; Rostaing L; Kamar N Clin J Am Soc Nephrol; 2012 Aug; 7(8):1310-9. PubMed ID: 22626959 [TBL] [Abstract][Full Text] [Related]
10. Pretransplant angiotensin II type 1-receptor antibodies are a risk factor for earlier detection of de novo HLA donor-specific antibodies. Cuevas E; Arreola-Guerra JM; Hernández-Méndez EA; Salcedo I; Castelán N; Uribe-Uribe NO; Vilatobá M; Contreras-Saldívar AG; Sánchez-Cedillo AI; Ramírez JB; de Rungs D; Granados J; Morales-Buenrostro LE; Alberú J Nephrol Dial Transplant; 2016 Oct; 31(10):1738-45. PubMed ID: 27220757 [TBL] [Abstract][Full Text] [Related]
11. The allograft injury marker CXCL9 determines prognosis of anti-HLA antibodies after lung transplantation. Shino MY; Zhang Q; Li N; Derhovanessian A; Ramsey A; Saggar R; Britton IN; Amubieya OO; Lari SM; Hickey M; Reed EF; Noble PW; Stripp BR; Fishbein GA; Lynch JP; Ardehali A; Sayah DM; Weigt SS; Belperio JA Am J Transplant; 2022 Feb; 22(2):565-573. PubMed ID: 34464505 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of donor-specific HLA antibodies in living versus deceased donor transplant. Kamburova EG; Wisse BW; Joosten I; Allebes WA; van der Meer A; Hilbrands LB; Baas MC; Spierings E; Hack CE; van Reekum FE; van Zuilen AD; Verhaar MC; Bots ML; Drop ACAD; Plaisier L; Seelen MAJ; Sanders JSF; Hepkema BG; Lambeck AJA; Bungener LB; Roozendaal C; Tilanus MGJ; Voorter CE; Wieten L; van Duijnhoven EM; Gelens M; Christiaans MHL; van Ittersum FJ; Nurmohamed SA; Lardy NM; Swelsen W; van der Pant KA; van der Weerd NC; Ten Berge IJM; Bemelman FJ; Hoitsma A; van der Boog PJM; de Fijter JW; Betjes MGH; Heidt S; Roelen DL; Claas FH; Otten HG Am J Transplant; 2018 Sep; 18(9):2274-2284. PubMed ID: 29464832 [TBL] [Abstract][Full Text] [Related]
13. Impact of Early Blood Transfusion After Kidney Transplantation on the Incidence of Donor-Specific Anti-HLA Antibodies. Ferrandiz I; Congy-Jolivet N; Del Bello A; Debiol B; Trébern-Launay K; Esposito L; Milongo D; Dörr G; Rostaing L; Kamar N Am J Transplant; 2016 Sep; 16(9):2661-9. PubMed ID: 26998676 [TBL] [Abstract][Full Text] [Related]